CDER QM CoE Announces Availability of Progress and Priorities Update
Today, the Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence (QM CoE) is pleased to announce the availability of the 2025 Progress and Priorities Update.
Established in 2024, the CDER QM CoE serves as a cooperative, coordinating body that drives innovation and fosters integration of quantitative medicine approaches to advance therapeutic medical product development, inform regulatory decision-making, and promote public health. This comprehensive progress report highlights the CDER QM CoE's significant accomplishments across three strategic areas: Enterprise Planning and Coordination, Applied Regulatory Science, and Education and Ecosystem Development.
The update provides stakeholders with key progress highlights and outlines the CDER QM CoE's evolving priorities for the future, guided by its established vision, mission, and values. The report also details the CDER QM CoE's strategic focus and plans for the coming years as it continues to advance quantitative medicine approaches in regulatory science.
Thank you to our collaborators for their support and partnership. For more information about the QM CoE and to read the report, please visit the QM CoE website.
The Office of Clinical Pharmacology (OCP) offers two e-mail subscription services, Clinical Pharmacology Corner and Quantitative Medicine, including Model-Informed Drug Development. These emails are a free service from FDA to provide occasional updates from OCP regarding newly approved therapies, new regulatory and scholarly publications, upcoming events, and other items of interest. Subscribe today or click the button below and select Clinical Pharmacology Corner and Quantitative Medicine, including Model-Informed Drug Development under DRUGS.
We always welcome your thoughts regarding the format, content, and utility of our communications. Comments may be sent via email to ocp@fda.hhs.gov.
This communication was prepared by the Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.
|
